SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $141,000 | -6.0% | 3,329 | -1.9% | 0.00% | -50.0% |
| Q3 2021 | $150,000 | -75.5% | 3,395 | -68.5% | 0.00% | -66.7% |
| Q2 2021 | $611,000 | +7.2% | 10,769 | +41.3% | 0.01% | 0.0% |
| Q1 2021 | $570,000 | -45.3% | 7,621 | +33.7% | 0.01% | -66.7% |
| Q2 2019 | $1,043,000 | +15.5% | 5,700 | +0.4% | 0.02% | +12.5% |
| Q1 2019 | $903,000 | +68.5% | 5,680 | +1.3% | 0.02% | +60.0% |
| Q4 2018 | $536,000 | -31.7% | 5,605 | +0.7% | 0.01% | -23.1% |
| Q3 2018 | $785,000 | -9.1% | 5,564 | +0.8% | 0.01% | -13.3% |
| Q2 2018 | $864,000 | – | 5,520 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |